Abel Hall LLC
ADMA icon

Abel Hall LLC’s ADMA Biologics ADMA Stock Holding History

Abel Hall LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$231K Sell
23,041
-877
-4% -$8.12K 0.04% 591
2026
Q2 		$200K Buy
+23,918
New +$218K 0.03% 744
2026
Q1 		– Sell
-19,884
Closed -$363K – 816
2025
Q4 		$363K Buy
+19,884
New +$335K 0.08% 253

Other funds holding ADMA

Marathon Capital Management
Marathon Capital Management Hunt Valley, Maryland $488M AUM 28.5% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Motley Fool Asset Management
Motley Fool Asset Management Alexandria, Virginia $2.64B AUM 26.58% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Abel Hall LLC's ADMA Position: Q3 2026 in Review

Abel Hall LLC reduced its ADMA Biologics (ADMA) stake by 3.7% in Q3 2026, selling an estimated $8.12K and leaving 23,041 shares worth $231K. The position accounts for 0.04% of the portfolio, ranked #591.

Abel Hall LLC first reported a position in ADMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $363K in Q4 2025. 91 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Abel Hall LLC held 23,041 shares of ADMA Biologics worth $231K as of Q3 2026.
  • Abel Hall LLC sold 877 ADMA Biologics shares in Q3 2026, an estimated $8.12K.
  • ADMA Biologics made up 0.04% of Abel Hall LLC's portfolio in Q3 2026, its #591 holding.
  • Abel Hall LLC first reported a position in ADMA Biologics in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's ADMA Biologics position peaked at $363K in Q4 2025.
  • 91 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.